Teams focused on cell therapy and diagnostics win first and second place at the Building a Biotech Venture Pitch Competition
Myoxa Therapeutics and Specifix Dx win the Building a Biotech Venture Pitch Competition
New Medicine by Design-supported research shows mature heart cells perform well in transplants
Study is an important step forward in researchers’ understanding of treating damaged hearts with cell therapies.
Medicine by Design’s Pivotal Experiment Fund invests $1 million in four research teams to bridge the “valley of death” funding gap
Funding gives cutting-edge regenerative medicine concepts impacting heart disease, lung transplantation, degenerative brain disease and end-stage liver disease a pathway to clinical translation.
Using stem cells to prevent heart failure
Medicine by Design-funded research team says the new treatment approach is not far from clinical trials. This is one of the ways Medicine by Design is transforming human health.